Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2019 | May 13, 2019 | |
Document Information [Line Items] | ||
Entity Registrant Name | OCULUS VISIONTECH INC. | |
Entity Central Index Key | 0001107280 | |
Trading Symbol | ovtz | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding (in shares) | 45,572,568 | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
ASSETS | ||
Cash and cash equivalents | $ 5,886 | $ 5,572 |
Prepaid expenses and other current assets | 1,290 | 1,192 |
Total current assets | 7,176 | 6,764 |
Deferred Tax Assets, net of valuation allowance of $6,556,000 and $6,545,000, respectively | ||
Total Assets | 7,176 | 6,764 |
Current Liabilities: | ||
Accounts payable and accrued expenses | 49,695 | 56,877 |
Accounts payable and accrued expenses - related parties | 745,695 | 685,421 |
Total current liabilities | 795,390 | 742,298 |
Commitments and Contingencies | ||
Stockholders' Deficiency: | ||
Preferred stock - no par value; authorized 250,000,000 shares, none issued | ||
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 45,572,568 | 40,458,297 | 40,458,297 |
Accumulated deficit | (41,246,511) | (41,193,831) |
Stockholders' deficiency | (788,214) | (735,534) |
Total Liabilities and Stockholders' Deficiency | $ 7,176 | $ 6,764 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ / shares in Thousands | Mar. 31, 2019 | Dec. 31, 2018 |
Deferred tax assets, valuation allowance | $ 6,556,000 | $ 6,545,000 |
Preferred stock, no par value (in dollars per share) | ||
Preferred stock, authorized (in shares) | 250,000,000 | 250,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Common stock, no par value (in dollars per share) | $ 0 | $ 0 |
Common stock, shares authorized (in shares) | 500,000,000 | 500,000,000 |
Common stock, shares issued (in shares) | 45,572,568 | 45,572,568 |
Common stock, shares outstanding (in shares) | 45,572,568 | 45,572,568 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Revenue | ||
Expenses: | ||
Research and development | 1,617 | |
Selling, general and administrative | 52,680 | 36,244 |
Total expenses | 52,680 | 37,861 |
Loss from operations | (52,680) | (37,861) |
Other income (expense) | ||
Interest income (expense) | ||
Net loss | $ (52,680) | $ (37,861) |
Net loss per share - basic and diluted (in dollars per share) | $ 0 | $ 0 |
Weighted-average number of common shares outstanding - basic and diluted (in shares) | 45,572,568 | 45,572,568 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Deficiency (Unaudited) - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Common Stock Including Additional Paid in Capital [Member] | ||
Balance (in shares) | 45,572,568 | |
Balance | $ 40,458,297 | |
Balance (in shares) | 45,572,568 | 45,572,568 |
Balance | $ 40,458,297 | $ 40,458,297 |
Retained Earnings [Member] | ||
Balance | (41,193,831) | |
Net Income (Loss) Attributable to Parent, Total | (52,680) | |
Balance | (41,246,511) | (41,193,831) |
Balance | (735,534) | |
Net Income (Loss) Attributable to Parent, Total | (52,680) | (183,279) |
Balance | $ (788,214) | $ (735,534) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Mar. 31, 2018 | |
Cash flows from operating activities: | ||
Net loss | $ (52,680) | $ (37,861) |
Changes in operating assets and liabilities: | ||
Decrease in accounts receivable | ||
Decrease (increase) in prepaid expenses and other current assets | (98) | (2,520) |
Increase (decrease) in accounts payable and accrued expenses | (7,182) | (13,370) |
Increase (decrease) in accounts payable and accrued expenses due to related parties | 60,274 | 54,698 |
Net cash used in operating activities | 314 | 947 |
Net increase in cash and cash equivalents | 314 | 947 |
Cash and cash equivalents at beginning of period | 5,572 | |
Cash and cash equivalents at end of period | 5,886 | 947 |
Supplemental disclosures of cash flow information: | ||
Cash paid during the period for interest | ||
Cash paid during the period for income taxes |
Note 1 - Basis of Presentation
Note 1 - Basis of Presentation | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | 1. BASIS OF PRESENTATION These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended December 31, 2018. not December 31, 2018, The accompanying consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiary, USVO Inc. All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are not may 10 December 31, 2018. |
Note 2 - Going Concern
Note 2 - Going Concern | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Substantial Doubt about Going Concern [Text Block] | 2. GOING CONCERN The accompanying unaudited condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern. As shown in the financial statements, the Company has incurred loss of $52,680 three March 31, 2019 $183,279 $230,699 December 31, 2018 2017, March 31, 2019, $41,246,511 $788,214. not |
Note 3 - Subsequent Events
Note 3 - Subsequent Events | 3 Months Ended |
Mar. 31, 2019 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | 3. SUBSEQUENT EVENTS None. |
Note 2 - Going Concern (Details
Note 2 - Going Concern (Details Textual) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Mar. 31, 2019 | Mar. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | |
Net Income (Loss) Attributable to Parent, Total | $ (52,680) | $ (37,861) | $ (183,279) | $ (230,699) |
Retained Earnings (Accumulated Deficit), Ending Balance | (41,246,511) | $ (41,193,831) | ||
Working Capital (Deficit) | $ (788,214) |